2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces microglial nitric oxide production and subsequent rat primary cortical neuron apoptosis through p38/JNK MAPK pathway

Ahn, 2012, Protective effects of agmatine on lipopolysaccharide-injured microglia and inducible nitric oxide synthase activity, Life Sci., 91, 1345, 10.1016/j.lfs.2012.10.010

Ajizian, 1999, J. Infect. Dis., 179, 939, 10.1086/314659

Bellavance, 2012, The neuroendocrine control of the innate immune system in health and brain diseases, Immunol. Rev., 248, 36, 10.1111/j.1600-065X.2012.01129.x

Butterfield, 2011, Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease, Free Radic. Res., 45, 59, 10.3109/10715762.2010.520014

Chang, 2001, Mammalian MAP kinase signalling cascades, Nature, 410, 37, 10.1038/35065000

Cheepsunthorn, 2001, Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain, Glia, 35, 53, 10.1002/glia.1070

Collins, 2008, 2,3,7,8-Tetracholorodibenzo-p-dioxin exposure disrupts granule neuron precursor maturation in the developing mouse cerebellum, Toxicol. Sci., 103, 125, 10.1093/toxsci/kfn017

Dawson, 1998, Nitric oxide in neurodegeneration, Prog. Brain Res., 118, 215, 10.1016/S0079-6123(08)63210-0

Garrington, 1999, Organization and regulation of mitogen-activated protein kinase signaling pathways, Curr. Opin. Cell Biol., 11, 211, 10.1016/S0955-0674(99)80028-3

Griess, 1879, Bemerkungen zu der Abhandlung der HH. Weselky und Benedikt Ueber einige Azoverbindungen, Ber. Dtsch. Chem. Ges., 12, 426, 10.1002/cber.187901201117

Hossain, 1998, The Ah receptor is not involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in human leukemic T cell lines, J. Biol. Chem., 273, 19853, 10.1074/jbc.273.31.19853

Knott, 2009, Nitric oxide in health and disease of the nervous system, Antioxid. Redox Signal., 11, 541, 10.1089/ars.2008.2234

Kwon, 2003, 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced activation of mitogen-activated protein kinase signaling pathway in Jurkat T cells, Pharmacol. Toxicol., 93, 186, 10.1034/j.1600-0773.2003.930406.x

Li, 2008, Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3T3-L1 adipocytes, Biochemistry, 47, 13997, 10.1021/bi801913w

Li, 2010, Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6J mice, Biol. Chem., 391, 1205, 10.1515/bc.2010.126

Liberatore, 1999, Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease, Nat. Med., 5, 1403, 10.1038/70978

Lijia, 2012, A self-propelling cycle mediated by reactive oxide species and nitric oxide exists in LPS-activated microglia, Neurochem. Int., 61, 1220, 10.1016/j.neuint.2012.09.002

Liu, 2012, A novel chromone derivative with anti-inflammatory property via inhibition of ROS-dependent activation of TRAF6-ASK1-p38 pathway, PLoS One, 7, e37168, 10.1371/journal.pone.0037168

Mates, 2010, Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms, Free Radic. Biol. Med., 49, 1328, 10.1016/j.freeradbiomed.2010.07.028

Mulero-Navarro, 2003, Down-regulation of CYP1A2 induction during the maturation of mouse cerebellar granule cells in culture: role of nitric oxide accumulation, Eur. J. Neurosci., 18, 2265, 10.1046/j.1460-9568.2003.02972.x

Munoz, 2010, Targeting p38 MAPK pathway for the treatment of Alzheimer's disease, Neuropharmacology, 58, 561, 10.1016/j.neuropharm.2009.11.010

Murphy, 2000, Production of nitric oxide by glial cells: regulation and potential roles in the CNS, Glia, 29, 1, 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N

Nakano, 1998, Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1, Proc. Natl. Acad. Sci. U. S. A., 95, 3537, 10.1073/pnas.95.7.3537

Nathan, 1994, Regulation of biosynthesis of nitric oxide, J. Biol. Chem., 269, 13725, 10.1016/S0021-9258(17)36703-0

Park, 2013, Britanin suppresses LPS-induced nitric oxide, PGE(2) and cytokine production via NF-kappaB and MAPK inactivation in RAW 264. 7 cells, Int. Immunopharmacol., 15, 296, 10.1016/j.intimp.2012.12.005

Park, 2005, 2,3,7,8-Tetrachlorodibenzo-p-dioxin activates ERK and p38 mitogen-activated protein kinases in RAW 264.7 cells, Anticancer Res., 25, 2831

Rothwell, 1993, Involvement of cytokines in acute neurodegeneration in the CNS, Neurosci. Biobehav. Rev., 17, 217, 10.1016/S0149-7634(05)80152-6

Sanchez-Martin, 2010, 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces apoptosis in neural growth factor (NGF)-differentiated pheochromocytoma PC12 cells, Neurotoxicology, 31, 267, 10.1016/j.neuro.2010.03.005

Sciullo, 2009, Characterization of the pattern of the nongenomic signaling pathway through which TCDD-induces early inflammatory responses in U937 human macrophages, Chemosphere, 74, 1531, 10.1016/j.chemosphere.2008.11.010

Sevko, 2013, Antitumor effect of Paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model, J. Immunol., 190, 2464, 10.4049/jimmunol.1202781

Shaked, 2012, Chronic epithelial NF-kappaB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation, Proc. Natl. Acad. Sci. U. S. A., 109, 14007, 10.1073/pnas.1211509109

Steinert, 2010, Nitric oxide signaling in brain function, dysfunction, and dementia, Neuroscientist, 16, 435, 10.1177/1073858410366481

Thellung, 2007, ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activation, Glia, 55, 1469, 10.1002/glia.20559

Vallejo, 2010, The role of glia and the immune system in the development and maintenance of neuropathic pain, Pain Pract., 10, 167, 10.1111/j.1533-2500.2010.00367.x

Xu, 2013, 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced inflammatory activation is mediated by intracellular free calcium in microglial cells, Toxicology, 308, 158, 10.1016/j.tox.2013.04.002

Yong, 2009, The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer, Expert Opin. Investig. Drugs, 18, 1893, 10.1517/13543780903321490